PRRT2 and left ventricular hypertrophy: Accumulation of advanced glycation end products (AGEs), activation of protein kinase C (PKC), transforming growth factor-β1 (TGF-β1), reactive oxygen species (ROS) which are closely related to the development of DKD also involved into the occurrence and progression of left ventricular hypertrophy [19].